Status
Conditions
Treatments
About
Non-randomized, open label, non-interventional, multicenter registry to describe risk factors, management strategies, and clinical outcomes in patients undergoing Valve in Valve (ViV) transcatheter aortic valve implantation (TAVI) in a previously implanted Trifecta or Epic valve using retrospective registry data from large volume centers
Full description
Anonymized pre-, intra-, and postoperative data will be collected from patients undergoing VinV TAVI in a previously implanted Trifecta™ valve, Trifecta™ GT, Epic™ or Epic™ Supra valve from the largest volume implanters of the Trifecta and Epic valve in Europe until June 2020. The data will be analyzed in order to give a comprehensive description of clinical outcomes for Trifecta VinV procedures, to identify preoperative risk factors for coronary obstruction, 30-day and 1-year mortality, and other major complications, and to analyze the effects of patient characteristics and / or protective maneuvers in order to prevent coronary obstruction.
Differences of Trifecta and Epic failed patients will also be analyzed.
Enrollment
Sex
Volunteers
Inclusion criteria
Exclusion criteria
76 participants in 2 patient groups
Loading...
Central trial contact
Michael Borger, MD, PhD; Matthias Raschpichler, MD, PhD
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal